Lifirafenib (BGB-283) is a novel potent and selective RAF Kinase and EGFR inhibitor with IC50 values of 23, 29 and 495 nM for the recombinant BRAFV600E kinase domain, EGFR and EGFR T790M/L858R mutant.
Molecular Weight:
478.42
Purity:
>98.5%
CAS Number:
[1446090-79-4]
Formula:
C25H17F3N4O3
Target:
Raf
* VAT and and shipping costs not included. Errors and price changes excepted